Followers | 195 |
Posts | 24755 |
Boards Moderated | 0 |
Alias Born | 04/03/2010 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, September 10, 2021 2:23:46 PM
It is easy to paint a horrible and dark, terrible picture and one that is incredibly better. I typically don’t spend too much time painting either picture though I do directly critique the doom and gloomers, as you know from personal experience.
I do not feel or see the current situation in the faux dark light you see it in, but you of course have every right to a dark opinion. Not everyone is of the same mind. That it all comes together at a moment before anticipated news that has been likely for some time on multiple fronts, and that timelines are often not met and sometimes you don’t want to wait for the publication that will simply take too long, these are common complaints but usually immaterial in the end.
The implication that they never complete anything, or never meet expectations is simply not true. The publication of blinded results was extremely impressive. And I expect these final results will confirm and likely better those results. But I believe that they are looking for more than basic OS data, they are looking for data that will help them on many levels and in the future with regard to biomarkers I expect. And those considerations, given when the trial started, may be more complicated, may have delayed parts of the effort, which I think is now focused on a future license for a general cancer vaccine.
Additionally, I think they want to be well on their way toward expedited approval, and the manufacturing part, they know, we all know, is a complicated part of that process.
The publication is for objective vindication. They may be less likely to just go for any publication and may be trying harder and that may require addressing rivals who are reviewing for publication. It is hard to know, but they likely have little control over that process. And who knows, in the end they could go with a different publication than they maybe hoped because of the delays and anxieties around them. Who knows.
None of it is bothering me. I consider this prime time. Not to say I don’t want it yesterday if that could happen. But I think NOW is prime time, the coming weeks and few months. And their last PR on manufacturing says that is what they HOPE as well. But no one can know for sure, not even the top executives at NWBO. Much of what happens is simply not 100% in their hands. In fact, it appears to me that a lot less in on their hands than people presume.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM